Because trinucleotide repeat expansion mutations in ATXN1, which augment the glutamine repeats in the encoded protein, underlie the development of spinocerebellar ataxia 1 (SCA1)70, miR-144 may play a protective role against this neurodegenerative disease. The gene discussed is ATXN1; the disease is spinocerebellar ataxia type 1.